Private equity firm Carlyle Group on Friday announced that it has agreed to acquire up to a 74 per cent stake in Indian animal healthcare company SeQuent Scientific Limited for about $210 million (Rs 1,580 crore).
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
